Liquid pharmaceutical injectable formulation of octreotide

Details Liquid pharmaceutical injectable formulation of octreotide Liquid pharmaceutical injectable formulation of octreotide

A - Human Necessities

61

K

A61K 38/08 (2006.01) A61J 1/14 (2006.01) A61K 9/08 (2006.01) A61L 2/00 (2006.01)

Patent

CA 2473412

A liquid pharmaceutical composition of pH between about 3 and about 9 comprising (a) octreotide (salt or base) of concentration from about 0.001 to about 5 g/L (under free-peptide form); (b) a suitable inorganic or organic buffer system; (c) in water; (d) in an appropriate container. The packaging material could be treated glass container, or constituted of another appropriate material with or without an elastomeric stopper.

Affiliated with

Also associated with

Rating

Liquid pharmaceutical injectable formulation of octreotide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid pharmaceutical injectable formulation of octreotide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid pharmaceutical injectable formulation of octreotide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2024255